Australia markets close in 6 hours 5 minutes

Pacific Biosciences of California, Inc. (PACB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.8100+0.0100 (+0.56%)
At close: 04:00PM EDT
1.8000 -0.01 (-0.55%)
After hours: 07:47PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 493.28M
Enterprise value 908.43M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.55
Price/book (mrq)1.00
Enterprise value/revenue 4.81
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 2.03
52-week change 3-81.30%
S&P500 52-week change 326.33%
52-week high 310.6500
52-week low 31.1600
50-day moving average 31.6316
200-day moving average 33.9086

Share statistics

Avg vol (3-month) 39.24M
Avg vol (10-day) 39.32M
Shares outstanding 5272.53M
Implied shares outstanding 6272.53M
Float 8270.98M
% held by insiders 11.87%
% held by institutions 185.98%
Shares short (30 Aug 2024) 461.03M
Short ratio (30 Aug 2024) 47.79
Short % of float (30 Aug 2024) 425.79%
Short % of shares outstanding (30 Aug 2024) 422.39%
Shares short (prior month 31 July 2024) 457.1M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 June 2024

Profitability

Profit margin -211.99%
Operating margin (ttm)-176.74%

Management effectiveness

Return on assets (ttm)-11.24%
Return on equity (ttm)-70.57%

Income statement

Revenue (ttm)188.87M
Revenue per share (ttm)0.71
Quarterly revenue growth (yoy)-24.30%
Gross profit (ttm)N/A
EBITDA -267.69M
Net income avi to common (ttm)-400.38M
Diluted EPS (ttm)-1.5000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)509.8M
Total cash per share (mrq)1.87
Total debt (mrq)924.95M
Total debt/equity (mrq)187.73%
Current ratio (mrq)8.01
Book value per share (mrq)1.81

Cash flow statement

Operating cash flow (ttm)-252.69M
Levered free cash flow (ttm)-297.27M